This study represents the first comprehensive analysis of the role of RPS6KC1 in the progression of PCa through the integration of CRISPR-based genome-wide and kinome-wide screens, scRNA-seq data from tumor tissues, and RNA-seq data from drug-resistant cells. Here, RPS6KC1 is linked to neoplasm.